Join Growin Stock Community!

Translational development acquisition corp.TDACW.US Overview

US StockIndustrials
(No presentation for TDACW)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

TDACW AI Insights

TDACW Overall Performance

TDACW AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

TDACW Recent Performance

15.15%

Translational development acquisition corp.

0.28%

Avg of Sector

-0.31%

S&P500

TDACW PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

TDACW Key Information

TDACW Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

TDACW Profile

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Price of TDACW

TDACW FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

TDACW Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.12
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
82.27%
Net Margin
-1772.62%
Revenue Growth (YoY)
-100.00%
Profit Growth (YoY)
-100.00%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
-100.00%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.12
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
82.27%
Net Margin
-1772.62%
Revenue Growth (YoY)
-100.00%
Profit Growth (YoY)
-100.00%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
-100.00%

  • When is TDACW's latest earnings report released?

    The most recent financial report for Translational development acquisition corp. (TDACW) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating TDACW's short-term business performance and financial health. For the latest updates on TDACW's earnings releases, visit this page regularly.

  • How much cash does TDACW have?

    At the end of the period, Translational development acquisition corp. (TDACW) held Total Cash and Cash Equivalents of 35.26K, accounting for 0 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • What are the PEG ratio and PE ratio of TDACW?

    The latest valuation data shows Translational development acquisition corp. (TDACW) has a Price-To-Earnings (PE) ratio of 10.44 and a Price/Earnings-To-Growth (PEG) ratio of -0. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.